| Dr Shiloh Gilbert, MD | |
|
9660 S 1300 E, Sandy, UT 84094-3762 | |
| (801) 501-2600 | |
| Not Available |
| Full Name | Dr Shiloh Gilbert |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 17 Years |
| Location | 9660 S 1300 E, Sandy, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114136132 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 141220 (North Carolina) | Secondary |
| 207P00000X | Emergency Medicine | 7625671-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intermountain Medical Center | Murray, UT | Hospital |
| Lds Hospital | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Utah Emergency Physicians | 1153307277 | 125 |
News Archive
Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.
The study, published in the journal Thorax, found that changes in the blood can be detected which signal the presence of lung cancer, and that these changes can be present years before outward symptoms become apparent.
Research led by St. Jude Children's Research Hospital scientists has produced new versions of an old antibiotic that are active against difficult-to-treat tuberculosis; offers new strategy for overcoming drug resistance
Biomedical informatics, one of the world's fastest-growing interdisciplinary fields, is the latest graduate degree program offered by the University of Chicago Graham School of Continuing Liberal and Professional Studies.
› Verified 7 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.
The study, published in the journal Thorax, found that changes in the blood can be detected which signal the presence of lung cancer, and that these changes can be present years before outward symptoms become apparent.
Research led by St. Jude Children's Research Hospital scientists has produced new versions of an old antibiotic that are active against difficult-to-treat tuberculosis; offers new strategy for overcoming drug resistance
Biomedical informatics, one of the world's fastest-growing interdisciplinary fields, is the latest graduate degree program offered by the University of Chicago Graham School of Continuing Liberal and Professional Studies.
› Verified 7 days ago
| Entity Name | Utah Emergency Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588048979 PECOS PAC ID: 1153307277 Enrollment ID: O20040628001454 |
News Archive
Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.
The study, published in the journal Thorax, found that changes in the blood can be detected which signal the presence of lung cancer, and that these changes can be present years before outward symptoms become apparent.
Research led by St. Jude Children's Research Hospital scientists has produced new versions of an old antibiotic that are active against difficult-to-treat tuberculosis; offers new strategy for overcoming drug resistance
Biomedical informatics, one of the world's fastest-growing interdisciplinary fields, is the latest graduate degree program offered by the University of Chicago Graham School of Continuing Liberal and Professional Studies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shiloh Gilbert, MD 9660 S 1300 E, Sandy, UT 84094-3762 Ph: (801) 501-2600 | Dr Shiloh Gilbert, MD 9660 S 1300 E, Sandy, UT 84094-3762 Ph: (801) 501-2600 |
News Archive
Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.
The study, published in the journal Thorax, found that changes in the blood can be detected which signal the presence of lung cancer, and that these changes can be present years before outward symptoms become apparent.
Research led by St. Jude Children's Research Hospital scientists has produced new versions of an old antibiotic that are active against difficult-to-treat tuberculosis; offers new strategy for overcoming drug resistance
Biomedical informatics, one of the world's fastest-growing interdisciplinary fields, is the latest graduate degree program offered by the University of Chicago Graham School of Continuing Liberal and Professional Studies.
› Verified 7 days ago
Gary H Lambert, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 9660 S 1300 E, Sandy, UT 84094 Phone: 801-269-2696 Fax: 801-269-2690 | |
Eddie C Iorg, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9660 S 1300 E, Sandy, UT 84094 Phone: 801-269-2500 Fax: 801-269-2690 | |
Kenneth Michael Jorgensen, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9660 S 1300 E, Sandy, UT 84094 Phone: 801-269-2696 Fax: 801-269-2690 | |
Jeffrey M Mcnally, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9660 S 1300 E, Sandy, UT 84094 Phone: 801-269-2696 Fax: 801-269-2690 | |
Dr. Isaac Joseph Bingham, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9660 S 1300 E, Sandy, UT 84094 Phone: 801-314-2875 | |
Adam F Ghiz, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 9660 S 1300 E, Sandy, UT 84094 Phone: 801-269-2696 Fax: 801-269-2690 |